Investor Relations

Investor updates

Where RubySDK investors read the current monthly update and stay on the list for the next one.

Private page for RubySDK investors. The update below is confidential and not for onward sharing.

Monthly update

RubySDK Investor Update — July 2026

Leading opportunities

GPU / Capacity Derivatives

Awaiting sign-off

50/50 JV with Capacify. GBP 125k Phase 1 Blueprint and Compute Desk benchmark proposed. Board paper due July.

Institutional finance and GPU compute

Affidea Switzerland

Under review

Healthcare AR and billing across 33 Swiss centres. EUR 50k Phase 1 Discovery, revised proposal submitted.

Healthcare

DataVault AI

Under review

Settlement infrastructure. GBP 125k Phase 1 Discovery proposal submitted.

Fintech

Key metrics

Lead JV Awaiting sign-off

Active engagements 10

Sectors covered 10

Ruby Token $0.01 → $0.20

Ruby Token is a utility token. $0.20 is the target Tier 1 listing price, not a current value.

The rest of the pipeline

UK Trade RetailRetail
Phase 1 live, awaiting client
X-ACMIAviation Client arranging Phase 1 funds
Delivered, in discussion
ReFrame for MusicMusic GBP 50k Phase 1 Blueprint
Proposal submitted
ReFrame Film FinanceFilm GBP 125k Phase 1 Blueprint, proposal submitted
Awaiting commencement
BeachMaster / BondiConsumer GBP 25k Phase 1
Discovery scoping
FootprintIQCyber / OSINT NDA stage
Partnership scoping
Nightingale & SentinelMedTech Own GBP 250k SEIS raise, not RubySDK
Discovery PRD submitted

Commentary

Every engagement runs on a fixed Phase 1 fee, with no equity and no dilution. Each one that goes live adds an independent source of Ruby Token demand.

What's next

Move the Capacify joint venture to sign-off and the July board paper.
Progress the outstanding proposals through review and commencement.
Advance the Ruby Token milestones toward the Tier 1 listing at $0.20.

Mark Abbott, RubySDK

Questions between updates? RubySDK's agent, Boris, can help.

Have a question? Ask Boris.